In addition, LAT2 could decrease GEM sensitivity, promote proliferation, inhibit apoptosis and activate glycolysis in pancreatic cancer cells, and these effects could be reversed by RAD001 treatment. This evidence concerns the gene LAT2 and familial pancreatic carcinoma.